Squarepoint’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Squarepoint’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-627,926	Closed	-$556K	–	4003
2022 Q4	$556K	Buy	627,926 +577,082	+1,135%	+$765K	﹤0.01%	2213
2022 Q3	$80K	Buy	+50,844	New	+$115K	﹤0.01%	2819
2022 Q2	–	Sell	-286,694	Closed	-$668K	–	3589
2022 Q1	$668K	Buy	+286,694	New	+$894K	﹤0.01%	1837
2021 Q4	–	Sell	-14,442	Closed	-$110K	–	3652
2021 Q3	$110K	Sell	14,442 -29,872	-67%	-$253K	﹤0.01%	2648
2021 Q2	$429K	Sell	44,314 -287,078	-87%	-$2.29M	﹤0.01%	2256
2021 Q1	$2.74M	Buy	331,392 +293,749	+780%	+$3.1M	0.02%	907
2020 Q4	$257K	Sell	37,643 -25,532	-40%	-$205K	﹤0.01%	2332
2020 Q3	$704K	Buy	63,175 +52,950	+518%	+$485K	0.01%	1202
2020 Q2	$64K	Sell	10,225 -31,775	-76%	-$122K	﹤0.01%	2076
2020 Q1	$77K	Sell	42,000 -119,262	-74%	-$344K	﹤0.01%	1680
2019 Q4	$545K	Buy	+161,262	New	+$384K	﹤0.01%	1724
2017 Q3	–	Sell	-13,602	Closed	-$27K	–	1962
2017 Q2	$27K	Buy	+13,602	New	+$26.5K	﹤0.01%	1483
2017 Q1	–	Sell	-16,116	Closed	-$79K	–	2012
2016 Q4	$79K	Buy	+16,116	New	+$96.8K	﹤0.01%	1656

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Squarepoint's SRNE Position: Q1 2023 in Review

Squarepoint sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 627,926 shares — an estimated $556K sold.

Squarepoint first reported a position in SRNE in Q4 2016 and held it in 13 quarters. The position peaked at $2.74M in Q1 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Squarepoint reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 627,926 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $556K.
Squarepoint first reported a position in Sorrento Therapeutics, Inc. in Q4 2016 and held it in 13 quarters.
Squarepoint's Sorrento Therapeutics, Inc. position peaked at $2.74M in Q1 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.